Population Health Partners, L.P. (PHP)
Amount not stated
Common stock warrant issued to PHP to purchase up to 6,824,712 shares at $3.48 per share, vesting in tranches on market capitalization targets
Each director opens the passage of the proxy that names them. "Not stated" means the proxy does not say; it never means "no". Pay is the proxy's Director Compensation table; the CEO is paid as an executive.
Common stock warrant issued to PHP to purchase up to 6,824,712 shares at $3.48 per share, vesting in tranches on market capitalization targets
Master Services Agreement and related work order with PHP, in connection with which the PHP Warrant was issued
Assignment and License Agreement under which we issued 5,000,000 shares of Series A preferred stock to Adimab in consideration for assigned rights and license
Payments to Adimab in connection with the Adimab Assignment Agreement
Royalty payments to Adimab under the Adimab Assignment Agreement
Payments to Adimab under the Adimab Collaboration Agreement (quarterly fees, research and option fees)
Upfront consideration paid to Adimab for rights under the Platform Transfer Agreement
Annual Fee payments to Adimab under the Platform Transfer Agreement
Payments to Adimab under the DNA Sequencing Services Agreement
LCMS Services Agreement with Adimab for molecular weight determination services; no payments made in the period
Loading...
